Harmony Biosciences Reports Third-Quarter Revenue of $268.9M
Story updates
12:32:24 PM UTC
SquawkNews
WAKIX ® Net Revenue in Q3 of $269 Million; Driven by Strong Demand with 400 Net Patient Adds in the
12:36:47 PM UTC
SquawkNews
WAKIX ® Net Revenue in Q3 of $269 Million; Driven by Strong Demand with 400 Net Patient Adds in the Quarter; Reiterates Full Year Guidance of $1.0B to $1.04BRepeated Once-Daily Dosing with BP-205 in Multiple-Ascending Dose Study Reinforces Favorable Safety, Tolerability and Pharmacokinetic Profile…
12:38:41 PM UTC
SquawkNews
*-- Earnings Flash (HRMY) Harmony Biosciences Holdings, Inc. Reports Q3 Revenue $268.9M, vs.
12:47:34 PM UTC
SquawkNews
HARMONY BIOSCIENCES SHARES DOWN 5.7% PREMARKET AFTER Q3 REVENUE, PRETAX PROFIT MISS